PEPTIDEHARBOR

Evidence Methodology

Human Clinical vs. Preclinical Evidence

Our evidence methodology draws a sharp line between human clinical data and preclinical findings. While in-vitro and animal model studies provide foundational mechanistic insights, we ensure readers understand that outcomes in mice do not directly translate to human efficacy or safety. Clinical evidence is always given overriding weight in our educational profiles.

Regulatory and Agency Evidence

We track and document the regulatory status of various peptides across global health agencies. When a compound has FDA approval or is listed on regulatory shortage lists, we clearly indicate its established medical context. Conversely, research chemicals lacking regulatory clearance are strictly categorized as experimental compounds.

Understanding the Limitations

Every reference on this platform has inherent limitations. Studies may have small sample sizes, conflicts of interest, or focus on isolated cellular pathways. We expect our readers to approach all published data with skepticism. We deliberately highlight conflicting studies and known side-effect profiles to provide a balanced overview.

Not Personalized Medical Advice

The theoretical calculators and reference dosages provided are designed for broad educational understanding of pharmacological mechanics. They do not account for individual biological differences, co-morbidities, or contraindications. None of the methodologies or data presented here constitute personalized medical advice or treatment recommendations.